December 14, 2005
Abstracts by academic fellow Julie Dumond and GlaxoSmithKline fellow Manoli Vourvahis have been accepted at the 13th Annual Conference on Retroviruses and Opportunistic Infections. Dumond and Vourvahis have each received a Young Investigator Award to attend the conference in February.
Dumond’s abstract “First Dose and Steady-state Genital Tract Pharmacokinetics of Ten Antiretroviral Drugs in HIV-infected Women: Implications for Pre- and Post- Exposure Prophylaxis” was accepted as an oral presentation. Vourvahis’ abstract “A Pharmacologic Basis for the Use of Tenofovir In Pre- and Post-exposure Prophylaxis: Intra- and Extracellular Genital Tract Pharmacokinetics and Pharmacodynamics from First Dose to Steady State in HIV-1 Infected Men and Women” was accepted as a poster.
The mission of CROI is to provide a forum for basic scientists and clinicians to present, discuss and critique their investigations into the biology and epidemiology of human retroviruses and the diseases they produce with the ultimate goal of translating laboratory and clinical research into progress against the AIDS epidemic.